Alu repeats contribute to genomic instability in primates via insertional and recombinational mutagenesis. Here, we report an analysis of Alu element-induced genomic instability through a novel mechanism termed retrotransposition-mediated deletion, and assess its impact on the integrity of primate genomes. For human and chimpanzee genomes, we find evidence of 33 retrotransposition-mediated deletion events that have eliminated approximately 9000 nucleotides of genomic DNA. Our data suggest that, during the course of primate evolution, Alu retrotransposition may have contributed to over 3000 deletion events, eliminating approximately 900 kb of DNA in the process. Potential mechanisms for the creation of Alu retrotransposition-mediated deletions include L1 endonuclease-dependent retrotransposition, L1 endonuclease-independent retrotransposition, internal priming on DNA breaks, and promiscuous target primed reverse transcription. A comprehensive analysis of the collateral effects by Alu mobilization on all primate genomes will require sequenced genomes from representatives of the entire order.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jmb.2005.02.043 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A high-quality human reference panel reveals the complexity and distribution of genomic structural variants.
Nat Commun
October 2016
European Research Institute for the Biology of Ageing, University of Groningen, University Medical Center Groningen, Groningen 9713AD, The Netherlands.
Structural variation (SV) represents a major source of differences between individual human genomes and has been linked to disease phenotypes. However, the majority of studies provide neither a global view of the full spectrum of these variants nor integrate them into reference panels of genetic variation. Here, we analyse whole genome sequencing data of 769 individuals from 250 Dutch families, and provide a haplotype-resolved map of 1.
View Article and Find Full Text PDFIdentification of human-specific AluS elements through comparative genomics.
Gene
January 2015
Department of Nanobiomedical Science & BK21 PLUS NBM Global Research Center for Regenerative Medicine, Dankook University, Cheonan 330-714, Republic of Korea; DKU-Theragen Institute for NGS Analysis (DTiNa), Cheonan 330-714, Republic of Korea. Electronic address:
Mobile elements are responsible for ~45% of the human genome. Among them is the Alu element, accounting for 10% of the human genome (>1.1million copies).
View Article and Find Full Text PDFRetrotransposable elements and human disease.
Genome Dyn
December 2008
Department of Biological Sciences, Biological Computation and Visualization Center, Center for BioModular Multi-Scale Systems, Louisiana State University, Baton Rouge, La., USA.
Nearly 50% of the human genome is composed of fossils from the remains of past transposable element duplication. Mobilization continues in the genomes of extant humans but is now restricted to retrotransposons, a class of mobile elements that move via a copy and paste mechanism. Currently active retrotransposable elements include Long INterspersed Elements (LINEs), Short INterspersed Elements (SINEs) and SVA (SINE/VNTR/Alu) elements.
View Article and Find Full Text PDFAn Alu retrotransposition-mediated deletion of CHD7 in a patient with CHARGE syndrome.
Am J Med Genet A
April 2007
Department of Pediatrics, Keio University School of Medicine, Tokyo, Japan.
CHD7 mutations account for about 60-65% among more than 200 CHARGE syndrome cases. When rare whole gene deletion cases associated with chromosomal abnormalities are excluded, all mutations of CHD7 reported to date have been point mutations and small deletions and insertions, rather than exonic deletions. To test whether exonic deletions represent a common pathogenic mechanism, we assessed exon copy number by using a recently developed method, the multiplex PCR/liquid chromatography assay (MP/LC).
View Article and Find Full Text PDFCharacterization of two unusual truncating PMM2 mutations in two CDG-Ia patients.
Mol Genet Metab
April 2007
Center for Human Genetics, University of Leuven, Herestraat 49, 3000 Leuven, Belgium.
Article Synopsis
- CDG-Ia is a recessive metabolic disorder caused by PMM2 gene mutations that impair N-glycan synthesis, leading to a wide range of clinical symptoms from severe organ failure to mild neurological issues.
- A significant number of PMM2 mutations are missense types, but the text presents two unusual truncating mutations found in two patients which are distinct from common mutations.
- The study highlights the importance of combining genomic DNA mutation screening with transcript analysis and enzymatic activity assessment to identify a broader spectrum of mutations, including deep intronic variants.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!